Good Samaritan University Hospital Awarded $500K Grant to Advance Special Pathogen Treatment Capabilities

Good Samaritan University Hospital is proud to announce its selection as a recipient of the Special Pathogen Treatment, Assessment, and Network Development (STAND) Award, a $500,000 grant from the National Emerging Special Pathogens Training and Education Center (NETEC), the nation’s leader in special pathogen preparedness and response. This funding will build/enhance Good Samaritan's capabilities as a Level 2 Special Pathogen Treatment Center (SPTC), which plays a crucial role in the National Special Pathogen System (NSPS). The NSPS is a tiered framework that ensures safe, high-quality care across the U.S. during high-consequence infectious disease (HCID) outbreaks. 

“Being recognized by the National Emerging Special Pathogens Training and Education Center is a tremendous honor and a reflection of our team’s unwavering commitment to preparedness, safety, and clinical excellence,” said Dr. Justin Lundbye, President of Good Samaritan University Hospital. “This designation underscores our role as a trusted regional resource and highlights the dedication of our physicians, nurses, and staff who work tirelessly to ensure our community is ready to respond to emerging public health threats.”

Selected through a competitive review process, Good Samaritan University Hospital, and other award recipients, are dedicated to advancing special pathogen preparedness. This award will support efforts to expand access to specialized care and strengthen readiness through activities such as staff training, equipment acquisition, and the development of systems for effective special pathogen care delivery. 

Throughout the award period, NETEC, in collaboration with the Regional Emerging Special Pathogen Treatment Centers (RESPTCs), will provide ongoing technical assistance, training, and verification support to help recipients meet Level 2 SPTC standards.